Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Product Outlook
3.3. Distribution Channel Outlook
3.4. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. United States Over The Counter Drugs Market, By Product
6.1. Introduction
6.2. Analgesics
6.3. Cough, Cold, and Flu Products
6.4. Dermatology Products
6.5. Gastrointestinal Products
6.6. Ophthalmic Products
6.7. Sleeping Aids
6.8. Vitamins, Mineral, and Supplements (VMS)
6.9. Weight-loss/Dietary Products


7. United States Over The Counter Drugs Market, By Distribution Channel
7.1. Introduction
7.2. Hospital Parmicies
7.3. Online Stores
7.4. Retail Pharmacies


8. 360iResearch Competitive Strategic Window
8.1. Introduction
8.2. 360iResearch Competitive Strategic Window, by Product
8.3. 360iResearch Competitive Strategic Window, by Distribution Channel


9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. 360iResearch Market Ranking Analysis
9.3. 360iResearch Market Share Analysis
9.4. 360iResearch Competitive Scenario
9.4.1. Merger & Acquisition
9.4.2. Agreement, Collaboration, & Partnership
9.4.3. New Product Launch & Enhancement
9.4.4. Investment & Funding
9.4.5. Award, Recognition, & Expansion


10. Company Usability Profiles
10.1. Abbott Laboratories
10.2. AbbVie Inc.
10.3. Achelios Therapeutics, Inc.
10.4. Arena Pharmaceuticals, Inc.
10.5. Bayer AG
10.6. Colgate-Palmolive Company
10.7. Gilead Sciences, Inc.
10.8. Innovus Pharmaceuticals, Inc.
10.9. Johnson & Johnson
10.10. Novartis AG
10.11. Pfizer Inc.
10.12. Procter & Gamble Company
10.13. Sanofi S.A.
10.14. Synergy Pharmaceuticals Inc


11. Appendix
11.1. Discussion Guide
11.2. Edition Details
11.3. License Details
11.4. Pricing Details



List of Figures



FIGURE 1. UNITED STATES OVER THE COUNTER DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES OVER THE COUNTER DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 6. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES OVER THE COUNTER DRUGS MARKET, BY TYPE
FIGURE 7. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES OVER THE COUNTER DRUGS MARKET: MARKET DYNAMICS
FIGURE 10. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 11. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2025
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 14. UNITED STATES OVER THE COUNTER DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 15. UNITED STATES OVER THE COUNTER DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS


List of Tables



TABLE 1. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES OVER THE COUNTER DRUGS MARKET: SCORES
TABLE 14. UNITED STATES OVER THE COUNTER DRUGS MARKET: BUSINESS STRATEGY
TABLE 15. UNITED STATES OVER THE COUNTER DRUGS MARKET: PRODUCT SATISFACTION
TABLE 16. UNITED STATES OVER THE COUNTER DRUGS MARKET: RANKING
TABLE 17. UNITED STATES OVER THE COUNTER DRUGS MARKET: MERGER & ACQUISITION
TABLE 18. UNITED STATES OVER THE COUNTER DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 19. UNITED STATES OVER THE COUNTER DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 20. UNITED STATES OVER THE COUNTER DRUGS MARKET: INVESTMENT & FUNDING
TABLE 21. UNITED STATES OVER THE COUNTER DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 22. UNITED STATES OVER THE COUNTER DRUGS MARKET: EDITION DETAILS
TABLE 23. UNITED STATES OVER THE COUNTER DRUGS MARKET: LICENSE DETAILS
TABLE 24. UNITED STATES OVER THE COUNTER DRUGS MARKET: PRICING DETAILS